Announcement on Convening the Q3 2024 Performance Briefing
Filed with SSE · · 3 pages · Chinese
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. on 6ix
Earlier from Sunshine Guojian Pharmaceutical (Shanghai)
- Report for Q3 2024
- Announcement on Implementation of Semi-annual Dividend Distribution in 2024
- Announcement on Completing Term Change and Election of Board of Directors and Board of Supervisors, and Appointing Senior Management Members and Securities Affairs Representative
- Announcement on Election of Employee Representative Supervisor
- Announcement on Convening Semi-annual Performance Briefing 2024
Later from Sunshine Guojian Pharmaceutical (Shanghai)
- Announcement on Change of Secretary of the Board of Directors
- Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Application Obtained by the Company's SSGJ-627 Injection
- Annual Earnings Preannouncement for 2024
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Preliminary Earnings Estimate for 2024
Follow Sunshine Guojian Pharmaceutical (Shanghai) into a list and get an email when it puts out news.
Follow Sunshine Guojian Pharmaceutical (Shanghai)